Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma Alvaro J. Alencar; Alexandre V. Hirayama; Diego V. Clé; Marco Aurélio Salvino; Guilherme Perini; Celso Arrais; Otávio Baiocchi; Leonardo Carvalho Palma; Iago Colturato; Jorge Vaz; Ricardo Chiattone; Marcos de Lima; Jayr Schmidt Filho; Samir Nabhan; Vanderson Rocha; Renato L. Guerino-Cunha; Carlos S. Chiattone;

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy Frank Nunes; Breno Moreno de Gusmão; Franciely Bueno Wiginesk; Euler Manenti; Juliana Soares; Mizianne Garcia Freitas; Juliane Dantas Seabra-Garcez; Alexandre Manoel Varela; João Pedro Passos Dutra; Bruno Cesar Bacchiega; Tânia Félix Lorenzato da Fonseca Peixoto; Carolina Maria Pinto Domingues de Carvalho e Silva; Renato D. Lopes; Ariane Vieira Scarlatelli Macedo;

Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR system Abbas Hajifathali; Maryam Vahdat Lasemi; Maryam Mehravar; Mohammad Reza Moshari; Afshin Mohammad Alizadeh; Elham Roshandel;